---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-076551"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2022-07-01T23:59:59+00:00"
generated_at: "2026-06-24T21:45:26.325138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA shareholders approve doubling authorized shares to 200M and reverse split range

## Summary
- Authorized common shares increased from 100M to 200M via Certificate of Amendment.
- Shareholders authorized reverse stock split in range of 1-for-2 to 1-for-10, if board elects.
- Class III directors Julie O'Neill and Reinhard Kandera elected for three-year terms.
- Stockholders ratified PwC Wirtschaftsprüfung GmbH as auditor for FY 2022.
- 2019 Stock Incentive Plan amended to increase authorized shares by 1M shares.

## SEC filing metadata
- accession: 0001104659-22-076551
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2022-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465922076551/0001104659-22-076551-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465922076551/tm2220184d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-076551
- JSON: https://secwatch.observer/filing/0001104659-22-076551.json
- Plain text: https://secwatch.observer/filing/0001104659-22-076551.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.